MSCI (MSCI) has laid out a clean set of numbers for Q2 2026, with revenue at US$867 million and basic EPS of US$4.70, set against a trailing twelve month EPS of US$18.29 and total revenue of about US$3.3 billion that highlight the scale of the business. Over the last year, the company has seen revenue move from US$2.9 billion to about US$3.3 billion and EPS rise from US$14.58 to US$18.29, giving investors a clear view of the revenue and earnings trajectory feeding into this quarter's print. With a recent net profit margin of 40.7%, these results put profitability firmly in focus for anyone tracking how efficiently MSCI is turning revenue into bottom line earnings.

See our full analysis for MSCI.

With the headline figures on the table, the next step is to set these results against the widely held narratives around MSCI to see which stories line up with the numbers and which might need a rethink.

MSCI’s profit engine in focus

• Over the last 12 months, MSCI generated about US$3.3b in revenue and US$1.4b in net income, which works out to a 40.7% net profit margin compared with 39.5% a year earlier.
• Consensus narrative points to rising demand for ETFs, ESG and analytics as a key driver of recurring, high margin revenue. The current 40.7% margin alongside trailing earnings growth of 15.2% gives bulls solid support, while also setting a high bar if fee pressure or slower subscription growth show up later.
  • Supporters highlight that recurring, subscription style revenue tied to indices and ESG data can help keep margins high, which lines up with the 40.7% net margin and 13.1% annual earnings growth over five years.
  • At the same time, the consensus view flags risks like fee compression and competition in index and data products, which could matter if future margins do not stay close to the recent 40.7% level.

Bulls argue that MSCI's strong profitability and recurring revenue make it more resilient than many peers, and the latest net margin figures give them plenty to talk about, but the real question is how long that advantage can last before competitors and fee pressure catch up. 🐂 MSCI Bull Case

Share price, P/E and growth expectations

• With the share price at US$570.95, MSCI trades on a trailing P/E of 30.6x compared with a peer average of 25.5x and a US Capital Markets industry average of 39x. Analysts have an average price target of US$694.41 and a DCF fair value of about US$651.48.
• Bears often focus on valuation and growth. Here they can point out that forecast revenue growth of about 8.1% and earnings growth of about 10% sit below broader US market forecasts of 12.8% for revenue and 17.8% for earnings, which can make a 30.6x P/E look demanding even if the stock trades about 12.4% below DCF fair value and analysts on average see roughly 21.6% upside to their targets.
  • Critics highlight that paying above the 25.5x peer P/E for slower than market growth relies heavily on MSCI maintaining its 40.7% net margin and 13.1% multi year earnings growth track record.
  • On the other hand, supporters of the higher multiple point to the combination of high profitability, a 1.44% dividend yield and analyst targets around US$694.41 as signals that quality and cash generation may matter more to some investors than headline growth rates.

Skeptics warn that if MSCI’s growth drifts further below the broader market while the P/E stays above peers, the stock could face pressure even if it sits below DCF fair value and the current analyst target range. 🐻 MSCI Bear Case

Quarterly trends behind MSCI’s growth story

• Looking at recent quarters, revenue moved from US$772.7 million in Q2 2025 to US$867 million in Q2 2026, while basic EPS over the same Q2 periods went from US$3.92 to about US$4.70. On a trailing 12 month basis, EPS stepped from US$15.13 in Q2 2025 to US$18.29 in Q2 2026.
• Analysts’ consensus view that MSCI can keep building on its index, ESG and analytics franchise is echoed in the 15.2% trailing earnings growth and the climb in trailing 12 month revenue from US$3.0b in Q2 2025 to about US$3.3b in Q2 2026. Their forward growth assumptions of about 8.1% for revenue and 10% for earnings are more moderate, which shows they are not simply extrapolating the recent 13.1% multi year earnings growth rate.
  • Supporters of the consensus view point to the steadily higher trailing EPS, from US$14.58 a year ago to US$18.29, as a sign that the business model has been converting revenue into earnings consistently.
  • At the same time, forecasts below broader US market growth acknowledge the risks flagged around fee compression, client budgets and competition, so the narrative builds in some restraint despite strong recent numbers.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for MSCI on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of confidence and caution around MSCI, it makes sense to review the numbers yourself and decide how the story fits your portfolio. Then weigh both sides of the narrative by checking the 5 key rewards and 2 important warning signs.

See What Else Is Out There

MSCI carries a P/E above peers while its forecast revenue and earnings growth sit below broader US market expectations, which can make valuation look demanding.

If you want stocks where pricing may better reflect growth potential right now, compare this setup with companies in the 47 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.